Citation: | DING Lili, LI Tingru, QIAN Lijun, SHI Chaoxiong, WANG Kai, LI Yansong, LU Miao. Correlation between systemic immune-inflammation index and heart failure in elderly patients with hypertension and nursing guidance: an data analysis based on National Health and Nutrition Examination Survey[J]. Journal of Clinical Medicine in Practice, 2024, 28(6): 118-123. DOI: 10.7619/jcmp.20233506 |
To explore the relationship of the systemic immune-inflammation index (SII) with heart failure incidence in elderly people with hypertension and its nursing implications.
According to the data of the National Health and Nutrition Examination Survey (NHANES) database from 1999 to 2010, a total of 5 607 hypertension patients aged 60 and above were screened out and divided into heart failure group with 437 cases and non-heart failure group with 5 170 cases. All the participants were divided into Q1 to Q4 groups based on their SII levels by using the quartile method, with Q1 as the reference group. After gradually adjusting for potential confounding factors, the differences in prevalence rate of heart failure among four groups were explored by Logistic regression analysis, and subgroup analyses were conducted as well.
There were significant differences in race, age, education level, income level, smoking history, drinking history, body mass index (BMI), C-reactive protein, estimated glomerular filtration rate (eGFR), hemoglobin, diabetes history and coronary heart disease history between the two groups (P < 0.05). Compared with the non-heart failure group, the heart failure group had significant lower lymphocyte and platelet counts, while the neutrophil count and SII were significantly higher (P < 0.05). The result of multiple Logistic regression analysis showed a positive correlation between the increase of SII and the prevalence rate of heart failure (P < 0.05). After adjusting for related confounding factors, the values of odds ratio (OR) and 95% confidence interval (95%CI) for prevalence rate of heart failure in patients with SII from the second to the fourth quartiles were 0.80 (0.57 to 1.11), 1.14 (0.84 to 1.56) and 1.38 (1.02 to 1.87) respectively (Ptrend=0.006). Subgroup analyses were carried out according to gender, diabetes, coronary heart disease, hyperlipidemia and eGFR, and the results showed that among women without coronary heart disease, with eGFR≤90 mL/(min·1.73 m2) and with or without hyperlipidemia, participants with the highest quartile of SII (Q4) had a significant higher risk of heart failure than those with Q1 (Ptrend < 0.05).
SII may be independently associated with the prevalence rate of heart failure in elderly people with hypertension, and has guiding significance for clinical and nursing work.
[1] |
BENETOS A, PETROVIC M, STRANDBERG T. Hypertension management in older and frail older patients[J]. Circ Res, 2019, 124(7): 1045-1060. doi: 10.1161/CIRCRESAHA.118.313236
|
[2] |
陈继兴, 陈世雄, 唐庆业, 等. 螺内酯联合乌拉地尔对老年高血压心力衰竭患者NYHA分级、心肌损伤血清学指标的影响[J]. 中国老年学杂志, 2023, 43(15): 3599-3602. doi: 10.3969/j.issn.1005-9202.2023.15.005
|
[3] |
SIDNEY S, QUESENBERRY C P Jr, JAFFE M G, et al. Heterogeneity in national U. S. mortality trends within heart disease subgroups, 2000-2015[J]. BMC Cardiovasc Disord, 2017, 17(1): 192. doi: 10.1186/s12872-017-0630-2
|
[4] |
HAO G, WANG X, CHEN Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015[J]. Eur J Heart Fail, 2019, 21(11): 1329-1337. doi: 10.1002/ejhf.1629
|
[5] |
DHANDE I S, DORIS P A. Genomics and inflammation in cardiovascular disease[J]. Compr Physiol, 2021, 11(4): 2433-2454.
|
[6] |
HANNA A, FRANGOGIANNIS N G. Inflammatory cytokines and chemokines as therapeutic targets in heart failure[J]. Cardiovasc Drugs Ther, 2020, 34(6): 849-863. doi: 10.1007/s10557-020-07071-0
|
[7] |
HU B, YANG X R, XU Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma[J]. Clin Cancer Res, 2014, 20(23): 6212-6222. doi: 10.1158/1078-0432.CCR-14-0442
|
[8] |
XIA Y Y, XIA C L, WU L D, et al. Systemic immune inflammation index (SⅡ), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42, 875 US adults[J]. J Clin Med, 2023, 12(3): 1128. doi: 10.3390/jcm12031128
|
[9] |
YUAN M, REN F X, GAO D F. The value of SⅡ in predicting the mortality of patients with heart failure[J]. Dis Markers, 2022, 2022: 3455372.
|
[10] |
TANG Y Y, ZENG X F, FENG Y L, et al. Association of systemic immune-inflammation index with short-term mortality of congestive heart failure: a retrospective cohort study[J]. Front Cardiovasc Med, 2021, 8: 753133. doi: 10.3389/fcvm.2021.753133
|
[11] |
ZHANG J, MAO Y K, LI Y S, et al. Association between migraine or severe headache and hypertension among US adults: a cross-sectional study[J]. Nutr Metab Cardiovasc Dis, 2023, 33(2): 350-358. doi: 10.1016/j.numecd.2022.11.014
|
[12] |
CAI J S, ZHANG L Y, CHEN C G, et al. Association between serum Klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007—2016[J]. Int J Cardiol, 2023, 370: 236-243. doi: 10.1016/j.ijcard.2022.11.010
|
[13] |
CHENG Y J, KANAYA A M, ARANETA M R G, et al. Prevalence of diabetes by race and ethnicity in the United States, 2011-2016[J]. JAMA, 2019, 322(24): 2389-2398. doi: 10.1001/jama.2019.19365
|
[14] |
WANG K, MAO Y K, LU M, et al. Association between serum Klotho levels and the prevalence of diabetes among adults in the United States[J]. Front Endocrinol, 2022, 13: 1005553. doi: 10.3389/fendo.2022.1005553
|
[15] |
WU L D, SHI Y, KONG C H, et al. Dietary inflammatory index and its association with the prevalence of coronary heart disease among 45, 306 US adults[J]. Nutrients, 2022, 14(21): 4553. doi: 10.3390/nu14214553
|
[16] |
DEFTEREOS S G, BEERKENS F J, SHAH B, et al. Colchicine in cardiovascular disease: In-depth review[J]. Circulation, 2022, 145(1): 61-78.
|
[17] |
LIBBY P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533. doi: 10.1038/s41586-021-03392-8
|
[18] |
JEBARI-BENSLAIMAN S, GALICIA-GARCÍA U, LARREA-SEBAL A, et al. Pathophysiology of atherosclerosis[J]. Int J Mol Sci, 2022, 23(6): 3346. doi: 10.3390/ijms23063346
|
[19] |
HENEIN M Y, VANCHERI S, LONGO G, et al. The role of inflammation in cardiovascular disease[J]. Int J Mol Sci, 2022, 23(21): 12906. doi: 10.3390/ijms232112906
|
[20] |
LING S, XU J W. NETosis as a pathogenic factor for heart failure[J]. Oxid Med Cell Longev, 2021, 2021: 6687096.
|
[21] |
KLOPF J, BROSTJAN C, EILENBERG W, et al. Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease[J]. Int J Mol Sci, 2021, 22(2): 559. doi: 10.3390/ijms22020559
|
[22] |
KURTUL A, ORNEK E. Platelet to lymphocyte ratio in cardiovascular diseases: a systematic review[J]. Angiology, 2019, 70(9): 802-818. doi: 10.1177/0003319719845186
|
[23] |
AZAB B, ZAHER M, WEISERBS K F, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction[J]. Am J Cardiol, 2010, 106(4): 470-476. doi: 10.1016/j.amjcard.2010.03.062
|
[24] |
XU J P, ZENG R X, ZHANG Y Z, et al. Systemic inflammation markers and the prevalence of hypertension: a NHANES cross-sectional study[J]. Hypertens Res, 2023, 46(4): 1009-1019. doi: 10.1038/s41440-023-01195-0
|
[25] |
CAO Y, LI P X, ZHANG Y, et al. Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES[J]. Front Immunol, 2023, 14: 1087345. doi: 10.3389/fimmu.2023.1087345
|